The relationship between high-sensitivity C-reactive protein at admission and post stroke depression: A 6-month follow-up study

International Journal of Geriatric Psychiatry

Volumn 31, Issue 3, 2016, Pages 231-239

  Yang, Rui Rui ^a   Lu, Bo Cheng ^b   Li, Tao ^c   Du, Yi Feng ^a   Wang, Xiang ^a   Jia, Yan Xia ^d  

^a SHANDONG UNIVERSITY   (China)

^b Central Hospital of Qilu Petrochemical Hospital Group   (China)

^c People's Hospital of Zhangqiu   (China)

^d JINING NO 1 PEOPLE S HOSPITAL   (China)

Author keywords

depression; high sensitivity C reactive protein; inflammation; stroke

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DSM-IV; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; STROKE PATIENT; SYMPTOM; ANALYSIS OF VARIANCE; METABOLISM; MIDDLE AGED; PSYCHOLOGY; RISK FACTOR; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOMARKERS; C-REACTIVE PROTEIN; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; STROKE; TIME FACTORS;

EID: 84958181787     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4315     Document Type: Article

References (44)

1. Adams HP, Bendixen B H, Kappelle LJ, et al,. 1993. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
2. Becking K, Boschloo L, Vogelzangs N, et al,. 2013. The association between immune activation and manic symptoms in patients with a depressive disorder. Transl psychiatr 3: e314.
3. Belmaker RH, Agam G,. 2008. Major depressive disorder. N Engl J Med 358: 55-68.
4. Bonita R BR,. 1988. Modification of Rankin Scale: recovery of motor function after stroke. Stroke 19: 1497-1500.
5. Brott T, Adams HP, Olinger CP, et al,. 1989. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20: 864-870.
6. Capuron L, Geisler S, Kurz K, et al,. 2014. Activated immune system and inflammation in healthy ageing: relevance for tryptophan and neopterin metabolism. Curr Pharm Des 20: 6048-6057.
7. Chen Z, Jalabi W, Shpargel KB, et al,. 2012. Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci 32: 11706-11715.
8. Cheng SY, Zhao YD, Li J, et al,. 2014. Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology 47: 126-135.
9. Cortese GP, Barrientos RM, Maier SF, Patterson SL,. 2011. Aging and a peripheral immune challenge interact to reduce mature brain-derived neurotrophic factor and activation of TrkB, PLCgamma1, and ERK in hippocampal synaptoneurosomes. J Neurosci 31: 4274-4279.
10. Di Napoli M, Papa F,. 2001. Inflammation, statins, and outcome after ischemic stroke. Stroke 32: 2446-2447.
11. D'Mello C, Le T, Swain MG,. 2009. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. J Neurosci 29: 2089-2102
12. Elkind M SV, Tai W, Coates K, et al,. 2006. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med 166: 2073-2080.
13. First M.B., Spitzer R.L., Gibbon M.,. 1995. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute: New York.
14. Ford DE, Erlinger TP,. 2004. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 164: 1010-1014.
15. Fujigaki H, Saito K, Fujigaki S, et al,. 2006. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem 139: 655-662.
16. Gimeno D, Marmot MG, Singh-Manoux A,. 2008. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 33: 1322-1334
17. Häfner S, Baghai TC, Eser D, et al,. 2008. C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients. J Psychiatr Res 42: 163-165.
18. Hamilton M,. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
19. Howren M B, Lamkin D M, Suls J,. 2009. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71: 171-186.
20. Huang L, Baban B, Johnson 3rd BA, et al,. 2010. Dendritic cells, indoleamine 2,3 dioxygenase and acquired immune privilege. Int Rev Immunol 29: 133-155.
21. Jesmin J., Rashid M.S., Jamil H., et al,. 2010. Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension. BMC Med Genomics; 3: 45.
22. Li J, Zhao YD, Zeng JW, et al,. 2014. Serum brain-derived neurotrophic factor levels in post-stroke depression. J Affect Disord 168: 373-379.
23. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, et al,. 2006. The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biol Psychiatry 60: 825-830.
24. Lucas M, Chocano-Bedoya P, Shulze M B, et al,. 2014. Inflammatory dietary pattern and risk of depression among women. Brain Behav Immun 36: 46-53.
25. Maes M,. 2011. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progr Neuropsychopharmacol Biol Psychiatr 35: 664-675.
26. Maes M, Berk M, Goehler L, et al,. 2012a. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 10: 66.
27. Maes M, Meltzer H Y, Scharpé S, et al,. 1993. Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: psychopathological correlates of hyperhaptoglobinemia during major depression. Psychiatry Res 47: 229-241.
28. Maes M, Mihaylova I, Kubera M, et al,. 2012b. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Progr Neuropsychopharmacol Biol Psychiatr 36: 169-175.
29. Norton SA, Sher-Glass R, Mann S, et al,. 2014. Inflammation and post-stroke depression: preliminary progress. Brain Behav Immun 40: e47.
30. Pasco JA, Nicholson GC, Williams LJ, et al,. 2010. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry 197: 372-377.
31. Rawdin BJ, Mellon SH, Dhabhar FS, et al,. 2013. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun 31: 143-152.
32. Ridker PM, Cushman M, Stampfer MJ, et al,. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979.
33. Rothenburg L S, Herrmann N, Swardfager W, et al,. 2010. The relationship between inflammatory markers and post stroke cognitive impairment. J Geriatr Psychiatry Neurol 23: 199-205.
34. Sanchez-Villegas A, Martinez-Gonzalez MA,. 2013. Diet, a new target to prevent depression? BMC Med 11: 3.
35. Sims J R, Gharai L R, Schaefer P W, et al,. 2009. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72: 2104-2110.
36. Thomas A J, O'Brien J T, Davis S, et al,. 2002. Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch Gen Psychiatry 59: 785-792.
37. Tu WJ, Zhao SJ, Liu TG, et al,. 2013. Combination of high-sensitivity C-reactive protein and homocysteine predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Neurol Res 35: 912-921.
38. Valkanova V, Ebmeier KP, Allan CL,. 2013. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 150: 736-744.
39. van Dijk EJ, Prins ND, Vermeer SE, et al,. 2005. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112: 900-905.
40. Vargas HO, Nunes S OV, de Castro M RP, et al,. 2013. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neurosci Lett 544: 136-140.
41. Welsh P, Lowe G DO, Chalmers J, et al,. 2008. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 39: 2226-2230.
42. Whiteley W, Jackson C, Lewis S, et al,. 2009. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 6: e1000145.
43. Wium-Andersen MK, Orsted DD, Nielsen SF, et al,. 2013. Elevated C-reactive protein levels, psychological distress, and depression in 73131 individuals. JAMA Psychiatr 70: 176-184.
44. Yue W, Xiang L, Zhang Y J, et al,. 2014. Association of serum 25-hydroxyvitamin D with symptoms of depression after 6 months in stroke patients. Neurochem Res 39: 2218-2224.